Effects of maturation on gentamicin disposition in neonates and infants
Marcadis, M.L.; Kraus, D.M.; Chow Tung, E.; Young, S.L.; Mcculloch, K.M.; Fischer, J.H.
Pharmacotherapy 11(3): 269
1991
ISSN/ISBN: 0277-0008 Accession: 031167923
Full Text Article emailed within 1 workday: $29.90
Related References
Germovsek, E.; Kent, A.; Metsvaht, T.; Lutsar, I.; Klein, N.; Turner, M.A.; Sharland, M.; Nielsen, E.I.; Heath, P.T.; Standing, J.F. 2016: Development and Evaluation of a Gentamicin Pharmacokinetic Model that Facilitates Opportunistic Gentamicin Therapeutic Drug Monitoring in Neonates and Infants Antimicrobial Agents and ChemoTherapy 60(8): 4869-4877Kearns, G.L.; Robinson, P.; Adcock, K.; Wilson Costello, D.; Knight, G.; Zhou, H.H.; Ward, R.; Van Den Anker, J.; Ppru Network 2001: Cisapride disposition in neonates and infants Clinical Pharmacology and Therapeutics 69(2): P31
Zoumboulakis, D.; Anagnostakis, D.; Arseni, A.; Nicolopoulos, D.; Matsaniotis, N. 1973: Gentamicin in the treatment of purulent meningitis in neonates and infants Acta Paediatrica Scandinavica 62(1): 55-58
Gentry, C.A.; Rodvold, K.A.; Plank, G.; Kraus, D.M.; Gross, J.R.; Nickel, E. 1994: A Bayesian pharmacokinetic model for gentamicin in neonates and infants Clinical Pharmacology and Therapeutics 55(2): 177
Semchuk, W.; Borgmann, J.; Bowman, L. 1993: Determination of a gentamicin loading dose in neonates and infants Therapeutic Drug Monitoring 15(1): 47-51
Kearns, G.L.; Jungbluth, G.L.; Abdel-Rahman, S.M.; Hopkins, N.K.; Welshman, I.R.; Grzebyk, R.P.; Bruss, J.B.; Van Den Anker, J.N. 2003: Impact of ontogeny on linezolid disposition in neonates and infants Clinical Pharmacology and Therapeutics 74(5): 413-422
Reed, M.D.; Gooch, W.M.; Minton, S.D.; Tanaka-Kido, J.; Santos, J.I.; Yamashita, T.S.; Blumer, J.L. 1991: Ceftizoxime disposition in neonates and infants during the first six months of life Dicp: the Annals of PharmacoTherapy 25(4): 344-347
Shahidullah, M.; Talukder, M.Q.; Chowdhury, A.K.; Ali, S.; Rashid, A. 1991: Serum levels of gentamicin at peak and trough in neonates and infants Indian Journal of Pediatrics 58(2): 217-221
Gilman, T.M.; Steinberg, I.; Yoshida, T.M. 1992: Population model for gentamicin pharmacokinetics in infants and neonates using npem Clinical Pharmacology and Therapeutics 51(2): 157
Levin, R.H. 1991: Principles of drug disposition and therapy in neonates infants and children Rudolph, A M (Ed ) Rudolph's Pediatrics, 19th Edition Xlii+2111p Appleton And Lange: East Norwalk, Connecticut, Usa; Prentice-Hall International (Uk) Ltd : London, England, Uk Illus Maps 859-862
Steinberg, I.; Yoshida, T.M.; Gilman, T.M. 1991: A population modeling approach and comparison of gentamicin pharmacokinetics in neonates and infants Pharmacotherapy 11(3): 274
Rodvold, K.A.; Gentry, C.A.; Plank, G.S.; Kraus, D.M.; Nickel, E.; Gross, J.R. 1993: Prediction of gentamicin concentrations in neonates and infants using a Bayesian pharmacokinetic model Developmental Pharmacology and Therapeutics 20(3-4): 211-219
Eshelman, F.N.; Snodgrass, G.L. 1976: Comparative levels of gentamicin in infants and neonates. A literature review and discussion American Journal of Pharmacy and the Sciences Supporting Public Health 148(2): 53-58
Jungbluth, G.L.; Welshman, I.R.; Hopkins, N.K.; Bruss, J.B.; Wu, E.; Kearns, G.L. 2002: Impact of gestational and postnatal age on linezolid disposition in neonates and young infants Pediatric Research 51(4 Part 2): 465A
Steinberg, I.; Gilman, T.M.; Yoshida, T.M. 1992: Comparison of statistical models for forecasting gentamicin g pharmacokinetics parameters in neonates and infants Clinical Pharmacology and Therapeutics 51(2): 158